>

WEBINARS

RSS
>

MEETINGS / EVENTS

RSS
>

FDA MEDWATCH ALERTS

RSS

January 12, 2012

Respironics, Inc. Trilogy 100 Ventilators: Class I Recall - Device May Stop Delivering Therapy to Patient

Summary:

FDA notified health care professionals of the Class 1 recall of this product due to a manufacturing issue can stop delivering therapy to the patient. Part of the blower that circulates air and other gases through the ventilator may move out of position and cause the device to alarm.  Failure to respond could result in the potential for harm or death of a ventilator-dependent patient.

January 12, 2012

Bedford Laboratories Vecuronium Bromide And Polymyxin B For Injection USP For Injection: Recall - Glass Particles

Summary:

Bedford Laboratories issued guidance on the nationwide voluntary product recalls originally issued on August 2, 2011. The recalls were initiated after the discovery of a visible glass particle in a limited number of vials within the lots listed.

January 09, 2012

Endo Pharmaceuticals Opiate Products by Novartis Consumer Health: Public Health Advisory - Potential Safety Risk

Summary:

FDA is advising health care professionals and patients of a potential problem with opiate products manufactured and packaged for Endo Pharmaceuticals by Novartis Consumer Health at its Lincoln, Nebraska manufacturing site.

>

ASA FEATURED PRODUCT

Self-Education and Evaluation (SEE) Program

SKU: 30701-12CE

... Read more »

Single Copies, Member Price: $300

History and Purpose of the ASARC

In 1988 the Resident Component of the American Society of Anesthesiologists was founded for three purposes.
  • To encourage resident participation in the ASA.
  • To develop experience in organized medicine among young physician leaders.
  • To improve resident awareness of the role of the ASA in the evolution of the specialty of Anesthesiology.

Since the ASARC was formed, ASA leadership has demonstrated an increased commitment to resident involvement in ASA activities. Through cooperation with the "Big House," residents have become voting members in the shaping of our specialty. Residents have been appointed adjunct members to ASA committees providing members with a first hand look at how ASA committee business is accomplished.

This year the resident component continues to allow residents voices to be heard at a national level by the recent infusion of new blood. As more residents become involved, then a stronger voice will be heard by the ASA House of Delegates. Only by becoming involved can we have a say in the continued improvements in our specialty. Residents represent the future and as such our voices should be heard in the direction our specialty takes. As a component of the ASA we are entitled to, and fully intend to use our votes to participate in the selection of our leaders over the coming years. We also use our votes to aid in the guidance of our specialty in the upcoming debates on medical reform.

To become involved in the running of the ASARC, and hence of the ASA there are several avenues available. First there is the state level. Most states have separate delegates representing approximately 50 residents each These delegates meet to discuss resident concerns of that particular state, then once a year they meet at the ASA national meeting. Five residents comprise the Resident Component Governing Council at the national level. These consist of a Chair, Chair-Elect, Delegate to the ASA, Alternate Delegate and Secretary. The State delegates present resolutions to the Resident Component House of Delegates each year at the annual ASA meeting in October. These resolutions may call for the Component to take an action, promote an activity or support a cause. A resolution may also call for the Component's representative delegate to introduce a resolution to the ASA House of Delegates or to the AMA Resident Component. These positions are voted upon annually. Positions are open to residents with 18 months or more of residency (including fellowship) left.